ArticleBioinformatics advances2025
Pathogenicity patterns in cytochrome P450 family.
Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Cytochrome P450 proteins play a crucial role in human metabolism, ranging from hormone production to drug metabolism. While multiple commonly known variants have known effects on the individual cytochrome P450 protein performance, the pathogenicity information is usually experimentally limited to only a few mutations. Current pathogenicity prediction software enables the extension of the scope to virtually mutate all amino acids with all possible substitutional mutations. In this work, we do a comprehensive exploration that unveils pathogenicity patterns in the human cytochrome P450 family. Pathogenicity analysis was conducted across proteins using SIFT, AlphaMissense, and PrimateAI-3D algorithms. Results: Our findings indicate a progressive increase in pathogenicity along protein tunnels-identified via MOLE-toward the cofactor binding site, underscoring the essential role of cofactor interactions in enzymatic function. Notably, the integrity of tunnels and cofactor environment emerges as a critical factor, with even single amino acid alterations potentially disrupting molecular guidance to active sites. These insights highlight the fundamental role of structural pathways in preserving cytochrome P450 functionality, with implications for understanding disease-associated variants and drug metabolism. Availability and implementation: Data and source code can be found at https://github.com/annaspac/P450_pathogenicity_codes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.